biosyn Arzneimittel GmbH
World market leader in high-dose selenium injections
biosyn Arzneimittel GmbH is a pharmaceutical and biotechnology company with headquarters in Fellbach near Stuttgart, Germany. It specializes in trace elements, a world market leader in high-dose selenium injections, and developer and operator of two worldwide unique GMP active substance manufacturing plants.
The company is furthermore active in the biotechnology field with a glycoprotein isolated
from Megathura crenulata, a sea snail whose natural habitat is off of California.
70 percent of sales is achieved outside of Germany, in 25 countries around the world. Active in the fields of intensive care, oncology and endocrinology, biosyn with its products is a partner for hospitals and private practice physicians as well as naturopaths and natural health practitioners. The company pursues research and development and evaluates current medical scientific literature and modern online marketing.
The mid-sized family-owned company places great value on an open, engaged and customer-oriented corporate culture.
Further information on the websites of BIOPRO Baden-Württemberg: